4/A//SEC Filing
Raleigh Jason Philip 4/A
Accession 0001437749-19-020745
CIK 0001389545other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 4:30 PM ET
Size
12.8 KB
Accession
0001437749-19-020745
Insider Transaction Report
Form 4/AAmended
Raleigh Jason Philip
Interim CFO and Treasurer
Transactions
- Sale
Common Stock
2019-06-10$3.00/sh−23,405$70,215→ 0 total - Exercise of In-Money
Stock Option (right to buy)
2019-06-10−23,405→ 0 totalExercise: $2.20From: 2019-05-31Exp: 2028-05-31→ Common Stock (23,405 underlying) - Award
Common Stock
2019-06-10$2.20/sh+23,405$51,491→ 23,405 total - Exercise of In-Money
Stock Option (right to buy)
2019-06-11−9,750→ 0 totalExercise: $2.35From: 2018-06-02Exp: 2027-06-02→ Common Stock (9,750 underlying) - Award
Common Stock
2019-06-11$2.35/sh+9,750$22,913→ 9,750 total - Sale
Common Stock
2019-06-11$3.75/sh−9,750$36,563→ 0 total
Footnotes (1)
- [F1]The amended Form 4 is being filed to show (1) the corresponding acquisition of common stock after the exercise of options in Table I and (2) the immediate sale of common stock after such exercise of options in Table I.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001771217
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 4:30 PM ET
- Size
- 12.8 KB